Bullboard - Stock Discussion Forum Enlivex Therapeutics Ltd ENLV

Healthcare Biotechnology

Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages... see more

Add To Watchlist

NDAQ:ENLV - Post Discussion

Enlivex Therapeutics Ltd > Enlivex Announces the Dosing of the First Patient in a Rando

View:

Post by whytestocks on Jun 24, 2024 4:30pm

Enlivex Announces the Dosing of the First Patient in a Rando

BREAKING NEWS: $ENLV Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb OsteoarthritisFirst patient dosed with Allocetra TM in thumb osteoarthritis, a degenerative, debilitating and progressive disease that affects millions of people Thumb osteoarthritis currently has no FDA-approved therapy and no effective long-term treatments Ness-Ziona, Israel, June 24, 2024 (GLO...ENLV - Enlivex Announces the Dosing of the First Patient in a Randomized, Placebo-Controlled Phase I/II Trial Evaluating AllocetraTM in up to 46 Patients with Thumb Osteoarthritis